| Gene symbol | KLRK1 | Synonyms | CD314, D12S2489E, KLR, NKG2-D, NKG2D | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p13.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | killer cell lectin like receptor K1 | ||||
| GTO ID | GTC3861 |
| Trial ID | NCT06379451 |
| Disease | Multiple Myeloma |
| Altered gene | NKG2D |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | NKG2D CAR-NK cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | An Exploratory Clinical Study of the Safety and Efficacy of NKG2D Chimeric Antigen Receptor NK Cell Injections for the Treatment of Efractory Recurrent Multiple Myeloma |
| Year | 2024 |
| Country | China |
| Company sponsor | Changzhou No.2 People's Hospital |
| Other ID(s) | [2023]YLJSA088 |
| Cohort 1 | |||||||||||
|
|||||||||||